O	0	3	The
O	4	11	effects
O	12	14	of
B-intervention	15	19	high
I-intervention	19	20	-
I-intervention	20	24	dose
I-intervention	25	35	calcitriol
I-intervention	36	39	and
I-intervention	40	54	individualized
I-intervention	55	63	exercise
O	64	66	on
O	67	71	bone
O	72	82	metabolism
O	83	85	in
B-eligibility	86	92	breast
I-eligibility	93	99	cancer
I-eligibility	100	109	survivors
I-eligibility	110	112	on
I-eligibility	113	121	hormonal
I-eligibility	122	129	therapy
O	129	130	:
O	131	132	a
O	133	138	phase
O	139	141	II
O	142	153	feasibility
O	154	159	trial
O	159	160	.

O	161	167	Cancer
O	168	177	treatment
O	177	178	-
O	178	185	induced
O	186	190	bone
O	191	195	loss
O	196	197	(
O	197	202	CTIBL
O	202	203	)
O	204	206	is
O	207	208	a
O	209	213	long
O	213	214	-
O	214	218	term
O	219	223	side
O	224	230	effect
O	231	233	of
O	234	240	breast
O	241	247	cancer
O	248	255	therapy
O	255	256	.

O	257	261	Both
O	262	272	calcitriol
O	273	276	and
O	277	283	weight
O	283	284	-
O	284	291	bearing
O	292	300	exercise
O	301	308	improve
O	309	313	bone
O	314	324	metabolism
O	325	328	for
O	329	341	osteoporotic
O	342	350	patients
O	350	351	,
O	352	355	but
O	356	359	are
O	360	368	unproven
O	369	371	in
O	372	373	a
O	374	380	breast
O	381	387	cancer
O	388	398	population
O	398	399	.

O	400	402	We
O	403	407	used
O	408	409	a
O	410	415	novel
O	416	420	high
O	420	421	-
O	421	425	dose
O	426	436	calcitriol
O	437	444	regimen
O	445	449	with
O	450	452	an
O	453	467	individualized
O	468	476	exercise
O	477	489	intervention
O	490	492	to
O	493	500	improve
O	501	505	bone
O	506	516	metabolism
O	517	519	in
O	520	526	breast
O	527	533	cancer
O	534	543	survivors
O	543	544	.

O	545	547	We
O	548	555	accrued
B-total-participants	556	558	41
O	559	567	subjects
O	568	570	to
O	571	575	this
O	576	580	open
O	581	586	label
O	586	587	,
O	588	589	2
O	590	591	×
O	592	593	2
O	594	603	factorial
O	603	604	,
O	605	615	randomized
O	616	627	feasibility
O	628	633	trial
O	633	634	.

O	635	641	Breast
O	642	648	cancer
O	649	658	survivors
O	659	663	were
O	664	674	randomized
O	675	677	to
O	678	685	receive
O	686	689	the
O	690	699	following
O	699	700	:
O	701	702	(
O	702	703	1
O	703	704	)
O	705	715	calcitriol
O	716	717	(
O	717	719	45
O	720	730	micrograms
O	730	731	/
O	731	735	week
O	735	736	)
O	736	737	,
O	738	739	(
O	739	740	2
O	740	741	)
O	742	756	individualized
O	757	765	exercise
O	766	770	with
O	771	782	progressive
O	783	790	walking
O	791	794	and
O	795	805	resistance
O	806	814	training
O	814	815	,
O	816	817	(
O	817	818	3
O	818	819	)
O	820	824	both
O	824	825	,
O	826	828	or
O	829	830	(
O	830	831	4
O	831	832	)
O	833	834	a
B-control	835	840	daily
I-control	841	853	multivitamin
I-control	854	855	(
I-control	855	862	control
I-control	863	872	condition
I-control	872	873	)
O	874	877	for
O	878	880	12
O	881	886	weeks
O	886	887	.

O	888	895	Primary
O	896	904	outcomes
O	905	913	included
B-outcome-Measure	914	921	changes
I-outcome-Measure	922	924	in
I-outcome-Measure	925	935	biomarkers
I-outcome-Measure	936	938	of
I-outcome-Measure	939	943	bone
I-outcome-Measure	944	953	formation
O	953	954	,
B-outcome-Measure	955	959	bone
I-outcome-Measure	960	970	resorption
O	970	971	,
O	972	975	and
O	976	979	the
B-outcome-Measure	980	984	bone
I-outcome-Measure	985	995	remodeling
I-outcome-Measure	996	1001	index
O	1001	1002	,
O	1003	1004	a
O	1005	1014	composite
O	1015	1022	measure
O	1023	1025	of
O	1026	1030	bone
O	1031	1040	formation
O	1041	1044	and
O	1045	1055	resorption
O	1055	1056	.

O	1057	1063	Safety
O	1064	1072	measures
O	1073	1081	included
O	1082	1090	clinical
O	1091	1094	and
O	1095	1106	biochemical
O	1107	1114	adverse
O	1115	1121	events
O	1121	1122	.

O	1123	1124	A
O	1125	1129	main
O	1130	1136	effect
O	1137	1145	analysis
O	1146	1149	was
O	1150	1154	used
O	1155	1158	for
O	1159	1164	these
O	1165	1174	endpoints
O	1174	1175	.

B-outcome	1176	1189	Hypercalcemia
O	1190	1193	was
O	1194	1201	limited
O	1202	1204	to
O	1205	1210	three
O	1211	1216	grade
O	1217	1218	I
O	1219	1224	cases
O	1225	1229	with
O	1230	1232	no
O	1233	1238	grade
O	1239	1240	≥
O	1241	1242	2
O	1243	1248	cases
O	1248	1249	.

O	1250	1255	Among
O	1256	1266	exercisers
O	1266	1267	,
O	1268	1271	100
O	1271	1272	%
O	1273	1280	engaged
O	1281	1283	in
O	1284	1287	the
O	1288	1298	prescribed
O	1299	1306	aerobic
O	1307	1315	training
O	1316	1319	and
O	1320	1322	44
O	1322	1323	.
O	1323	1324	4
O	1324	1325	%
O	1326	1333	engaged
O	1334	1336	in
O	1337	1340	the
O	1341	1351	prescribed
O	1352	1362	resistance
O	1363	1371	training
O	1371	1372	.

O	1373	1383	Calcitriol
O	1384	1397	significantly
B-outcome	1398	1406	improved
I-outcome	1407	1411	bone
I-outcome	1412	1421	formation
O	1422	1423	(
O	1423	1428	Cohen
O	1428	1429	'
O	1429	1430	s
O	1431	1432	d
O	1433	1434	=
O	1435	1436	0
O	1436	1437	.
O	1437	1439	64
O	1439	1440	;
O	1441	1442	p
O	1443	1444	<
O	1445	1446	0
O	1446	1447	.
O	1447	1449	01
O	1449	1450	)
O	1450	1451	,
O	1452	1461	resulting
O	1462	1464	in
O	1465	1466	a
O	1467	1470	non
O	1470	1471	-
O	1471	1482	significant
O	1483	1491	increase
O	1492	1494	in
O	1495	1498	the
B-outcome	1499	1503	bone
I-outcome	1504	1514	remodeling
I-outcome	1515	1520	index
O	1521	1522	(
O	1522	1527	Cohen
O	1527	1528	'
O	1528	1529	s
O	1530	1531	d
O	1532	1533	=
O	1534	1535	0
O	1535	1536	.
O	1536	1538	21
O	1538	1539	;
O	1540	1541	p
O	1542	1543	=
O	1544	1546	31
O	1546	1547	)
O	1547	1548	.

O	1549	1557	Exercise
O	1558	1564	failed
O	1565	1567	to
B-outcome	1568	1575	improve
I-outcome	1576	1579	any
I-outcome	1580	1582	of
I-outcome	1583	1586	the
I-outcome	1587	1591	bone
I-outcome	1592	1602	biomarkers
O	1602	1603	.

O	1604	1608	Both
O	1609	1619	calcitriol
O	1620	1623	and
O	1624	1632	exercise
O	1633	1637	were
O	1638	1643	shown
O	1644	1646	to
O	1647	1649	be
O	1650	1658	feasible
O	1659	1662	and
B-outcome	1663	1667	well
I-outcome	1668	1677	tolerated
O	1677	1678	.

O	1679	1689	Calcitriol
O	1690	1703	significantly
O	1704	1712	improved
B-outcome	1713	1717	bone
I-outcome	1718	1727	formation
O	1727	1728	,
O	1729	1738	resulting
O	1739	1741	in
O	1742	1743	a
O	1744	1747	net
O	1748	1756	increase
O	1757	1759	of
O	1760	1764	bone
O	1765	1775	metabolism
O	1775	1776	.

O	1777	1787	Compliance
O	1788	1792	with
O	1793	1796	the
O	1797	1805	exercise
O	1806	1818	intervention
O	1819	1822	was
O	1823	1826	sub
O	1826	1827	-
O	1827	1834	optimal
O	1834	1835	,
O	1836	1841	which
O	1842	1845	may
O	1846	1850	have
O	1851	1854	led
O	1855	1857	to
O	1858	1859	a
O	1860	1864	lack
O	1865	1867	of
O	1868	1874	effect
O	1875	1877	of
O	1878	1886	exercise
O	1887	1889	on
O	1890	1894	bone
O	1895	1905	metabolism
O	1905	1906	.
